KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sarepta Therapeutics (SRPT) Non-Current Assets (2016 - 2025)

Historic Non-Current Assets for Sarepta Therapeutics (SRPT) over the last 15 years, with Q3 2025 value amounting to $771.1 million.

  • Sarepta Therapeutics' Non-Current Assets fell 1568.36% to $771.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.7 billion, marking a year-over-year increase of 1988.97%. This contributed to the annual value of $889.7 million for FY2024, which is 2983.82% up from last year.
  • Per Sarepta Therapeutics' latest filing, its Non-Current Assets stood at $771.1 million for Q3 2025, which was down 1568.36% from $1.0 billion recorded in Q2 2025.
  • Sarepta Therapeutics' Non-Current Assets' 5-year high stood at $1.0 billion during Q1 2025, with a 5-year trough of $476.9 million in Q3 2021.
  • For the 5-year period, Sarepta Therapeutics' Non-Current Assets averaged around $676.9 million, with its median value being $653.3 million (2023).
  • Per our database at Business Quant, Sarepta Therapeutics' Non-Current Assets soared by 3881.06% in 2024 and then crashed by 1568.36% in 2025.
  • Sarepta Therapeutics' Non-Current Assets (Quarter) stood at $543.9 million in 2021, then grew by 4.9% to $570.5 million in 2022, then grew by 20.11% to $685.2 million in 2023, then grew by 29.84% to $889.7 million in 2024, then fell by 13.33% to $771.1 million in 2025.
  • Its Non-Current Assets was $771.1 million in Q3 2025, compared to $1.0 billion in Q2 2025 and $1.0 billion in Q1 2025.